LIC Vodafone Idea Lead Mondays Market Movers Max Healthcare JSW Cement Slip Oil Prices Gain as Irans Nuclear Stance Heightens Geopolitical Tensions Gold Prices Dip as Feds Waller Flags Potential Rate Hike Amid Iran Energy Shock UK Exports to US Plunge 25 After Trumps Liberation Day Tariffs Government Reaffirms NonInterventionist Stance on Rupee Exchange Rates Says Minister Goyal Novartis Raises FullYear Sales and Profit Guidance Amid Strong Operational Performance Target Hospitality Corp TH Q1 2026 Earnings EPS Misses Estimates Amidst Operational Challenges Tri Pointe Homes Q1 2026 Earnings Earnings Miss Expectations Amid Challenging Market Conditions BR Q1 2026 Earnings EPS Beats Estimates as Operational Efficiency Drives Profitability CTNT Q1 2026 Earnings NarrowerthanExpected Loss Fails to Lift Shares DigitalOcean DOCN Q1 2026 Earnings Massive EPS Beat of 626 Surprises Market Acadia Healthcare Q1 2026 Earnings Strong EPS Surprise Drives Modest Stock Uptick Brunswick Corporation BC Shares Bounce 282 as Stock Recovers Toward Key Resistance MIND CTI MNDO Bounces 326 Nearing Key Resistance at 10 First Capital Inc FCAP Gains 095 Resilience Near Support Zone After Modest Rally Four Seasons Education FEDU Surges 79 as Stock Breaks Above Key Support Invesco California Value Municipal Income Trust VCV Edges Higher Amid Steady Trading ADP Employment Report Shows Private Payrolls Rose by 109000 in April Exceeding Estimates FTRE Q1 2026 Earnings Significant EPS Beat Driven by Operational Improvements Magna International MGA Gains 146 as Stock Tests Key Resistance Levels Limoneira Co LMNR Shows Modest Gains Amid Consolidation Near Resistance Universal Insurance Holdings UVE Stock Declines 129 as Shares Approach Support Level Credit Suisse Asset Management Income Fund Inc CIK Holds Steady at 252 Amid Narrow Trading Range Weatherford International WFRD Holds Steady Near Support Amid Quiet Trading AGNC Investment Corp Preferred Shares AGNCP Edge Higher Stability in a Volatile Rate Landscape Smithfield Foods Inc SFD Gains Ground Approaches Key Resistance Lexeo Therapeutics LXEO Slips 229 as Stock Tests Key Support Levels